Rigetti Computing Faces Mounting Investor Concerns

Rigetti US76655K1034

A recent analyst downgrade has cast a shadow over Rigetti Computing, raising fresh questions about the quantum computing firm's valuation, revenue trajectory, and future capital requirements. These concerns are amplified by operational delays and a stark performance gap when measured against its closest competitor.

• Investment bank TD Cowen downgraded its rating on Rigetti from "Buy" to "Hold."
• The firm's revenue projection for 2027 was slashed to approximately $30 million, far below the consensus estimate of around $55 million.
• Plans for a new chip fabrication facility carry an estimated price tag exceeding $300 million.
• The company holds roughly $525 million in cash but has an annual cash burn rate of $70–80 million.
• Third-quarter revenue came in at $1.9 million, an 18.1% year-over-year decline. Competitor IonQ reported Q3 revenue of $39.87 million.
• General availability of the 108-qubit Cepheus-1-108Q processor has been postponed to the end of Q1 2026.

Downgrade Highlights Valuation and Growth Concerns

The shift in sentiment was triggered by TD Cowen analyst Krish Sankar, who moved his recommendation on the stock to "Hold" this week. Central to this reassessment is the viability of the aggressive revenue growth currently priced into the equity by many investors.

TD Cowen's research suggests the market's sales expectations are overly optimistic. The bank's revised financial model now forecasts 2027 revenue near $30 million, a figure that stands in sharp contrast to the broader analyst consensus of about $55 million. This revision reflects a view that the commercialization of quantum computing may progress more slowly than previously anticipated.

Capital Intensity and Funding Questions Emerge

Beyond growth assumptions, Rigetti's significant future capital needs are drawing increased scrutiny. The company aims to construct a new manufacturing plant to improve chip yields, a project estimated to cost more than $300 million.

While Rigetti's current cash position of approximately $525 million appears substantial, its consistent $70–80 million annual cash consumption raises questions about future financing. Analysts are weighing the possibility that the company may need to raise additional capital later, which could potentially dilute existing shareholders.

Competitive Disparity and Setbacks Compound Challenges

The company's operational performance further fuels the cautious outlook. Rigetti's Q3 revenue of $1.9 million not only represented a decline but was also dwarfed by IonQ's $39.87 million result for the same period—a multiple of roughly twenty times.

The company also faced a setback in public funding. Rigetti was not selected for Stage B of the DARPA Quantum Benchmarking Initiative (QBI), a program that awarded contracts to IonQ and IBM. This exclusion means Rigetti misses out on a potential revenue stream that could have exceeded $1 million per quarter.

On the product development front, a key milestone has been pushed back. The company confirmed a delay in the broad release of its 108-qubit Cepheus-1-108Q processor. The launch is now scheduled for the end of the first quarter of 2026 to address technical hurdles related to gate fidelity.

Closing the week at $16.09, Rigetti's shares declined approximately 9% over the five-day period. Despite these headwinds, the company maintains a market capitalization near $5 billion. TD Cowen notes that Rigetti's valuation multiples, such as enterprise value to sales, remain elevated compared to industry peers, which in the analysts' view continues to reflect optimistic growth scenarios.